KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Interest & Investment Income: 2016-2025

Historic Interest & Investment Income for CareDx (CDNA) over the last 9 years, with Sep 2025 value amounting to $2.0 million.

  • CareDx's Interest & Investment Income fell 32.92% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.2 million, marking a year-over-year decrease of 13.96%. This contributed to the annual value of $11.8 million for FY2024, which is 0.86% down from last year.
  • Per CareDx's latest filing, its Interest & Investment Income stood at $2.0 million for Q3 2025, which was down 14.85% from $2.4 million recorded in Q2 2025.
  • CareDx's Interest & Investment Income's 5-year high stood at $3.2 million during Q3 2023, with a 5-year trough of $1,000 in Q2 2021.
  • Over the past 3 years, CareDx's median Interest & Investment Income value was $2.9 million (recorded in 2023), while the average stood at $2.8 million.
  • In the last 5 years, CareDx's Interest & Investment Income tumbled by 95.24% in 2021 and then skyrocketed by 47,700.00% in 2022.
  • CareDx's Interest & Investment Income (Quarterly) stood at $13,000 in 2021, then soared by 14,284.62% to $1.9 million in 2022, then skyrocketed by 68.93% to $3.2 million in 2023, then declined by 3.36% to $3.1 million in 2024, then crashed by 32.92% to $2.0 million in 2025.
  • Its Interest & Investment Income stands at $2.0 million for Q3 2025, versus $2.4 million for Q2 2025 and $2.8 million for Q1 2025.